The historical rank and industry rank for RVL Pharmaceuticals's Days Inventory or its related term are showing as below:
RVLPQ's Days Inventory is not ranked *
in the Biotechnology industry.
Industry Median: 183.97 * Ranked among companies with meaningful Days Inventory only.
RVL Pharmaceuticals's Days Inventory
increased
from Jun. 2022 (27.99) to Jun. 2023 (36.79).
It might indicate that RVL Pharmaceuticals's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
RVL Pharmaceuticals's Inventory Turnover for the
three
months ended in Jun. 2023 was 2.48.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
RVL Pharmaceuticals's Inventory-to-Revenue for the
three
months ended in Jun. 2023 was 0.09.
RVL Pharmaceuticals (OTCPK:RVLPQ) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
RVL Pharmaceuticals's Inventory Turnover for the
three
months ended in Jun. 2023 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
RVL Pharmaceuticals's Inventory to Revenue for the
three
months ended in Jun. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
RVL Pharmaceuticals Days Inventory Related Terms
RVL Pharmaceuticals Days Inventory Historical Data
* Premium members only.
The historical data trend for RVL Pharmaceuticals's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
RVLPQ vs SNPX, THAR, SLRX: Days Inventory Comparison
For the Biotechnology subindustry, RVL Pharmaceuticals's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
RVL Pharmaceuticals Days Inventory vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, RVL Pharmaceuticals's Days Inventory distribution charts can be found below:
* The bar in red indicates where RVL Pharmaceuticals's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
RVL Pharmaceuticals (RVLPQ) has a Days Inventory of 36.79 as of Jun. 2023. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on RVL Pharmaceuticals and its competitors.
Is RVL Pharmaceuticals' Days Inventory too high?
RVL Pharmaceuticals' current Days Inventory is 36.79. The Biotechnology industry median Days Inventory is 183.97. RVL Pharmaceuticals' value of 36.79 is 80% below this industry median. Overall, RVL Pharmaceuticals has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does RVL Pharmaceuticals' Days Inventory compare to SNPX and THAR?
RVL Pharmaceuticals' Days Inventory of 36.79 can be compared against companies in the Biotechnology industry. The industry median Days Inventory is 183.97. RVL Pharmaceuticals' value of 36.79 is 80% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.97, based on 639 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. RVL Pharmaceuticals's current Days Inventory of 36.79 is 80% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on RVL Pharmaceuticals and its competitors. For the Biotechnology industry, the median Days Inventory is 183.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. RVL Pharmaceuticals's current Days Inventory is 36.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RVL Pharmaceuticals stock overvalued right now?
RVL Pharmaceuticals (RVLPQ) has a current Days Inventory of 36.79. The current Days Inventory is 36.79 and 80% below the Biotechnology industry median of 183.97. RVL Pharmaceuticals' overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For RVL Pharmaceuticals (RVLPQ), the current Days Inventory is 36.79 as of Jun. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
RVL Pharmaceuticals PLC is a pharmaceutical company focused on the commercialization and development of products that target markets with underserved patient populations in the ocular medicine and medical aesthetics therapeutic areas. Its revenues consist of product sales, royalty revenues and licensing revenue.
12GF Score
Get the complete analysis for RVLPQ
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RVLPQ has been successfully added to your 
